Professor E D Williams (Royal Infirmary, Cardiff, CF2 ISZ) said that he wished to stress the inheritance of medullary carcinoma of the thyroid. This tumour could be regarded as being either 'sporadic' or 'genetic'. The sporadic tumours formed the largest groupperhaps 85% or 90% of all medullary carcinomas. In these patients the tumour usually presented in middle or late life, was usually unilateral and was probably not associated with pheochromocytomas. The genetic group usually presented with their tumour below the age of 30; the tumour was frequently bilateral and was often associated with ph2ochromocytomas -also frequently bilateral. Analysis of 13 families, from the literature and personally studied, suggested that when the tumour was inheritedwith or without phiochromocytomait was inherited as an autosomal dominant of almost complete penetrance. Multiple mucosal neuromas formed a characteristic syndrome that occurred occasionally with the genetic group and probably not with the sporadic group. The facial appearance of these patients was remarkably similar, and any patient with this appearance should be carefully investigated for both medullary carcinoma and phiochromocytoma.
Professor E D Williams then contributed a paper entitled Ectopic Hormone Production by Tumours. Dr G M Besser (Medical Unit, St Bartholomew's Hospital, London ECJ) said that production of ectopic ACTH-like polypeptides by a tumour was always associated with excess melanocytestimulating-hormone-like polypeptide production, in the same way that MSH and ACTH secretion from the pituitary were always associated (Liddle 1968 , Orth et al. 1968 , Abe et al. 1969 . Since the precise peptide sequence within the ACTH molecule necessary for steroidogenic potency was very specific, and only slight modification in the structure of the first 24 amino-acid 'N-terminal' sequence resulted in complete loss of steroidogenic activity, it followed that the 'ectopic' ACTH-like peptide was very closely related to the N-terminal structure, as was confirmed by the immunological and physiochemical characteristics of this material. However, other peptides related to ACTH but with little or no steroidogenic activity were also produced. Thus, when antibodies reacting with the non-steroidogenic 'C-terminal' portion of the ACTH molecule (amino acids 25-39) had been used to measure the ACTH-like material in tumour extracts, a greater amount of C-terminal reactive material had sometimes been found compared with the amount of steroidogenic N-terminal material in the same tumour. This suggested that peptides containing some or all of the C-terminal ACTH peptide sequence might be produced separately from those peptides which had steroidogenic activity, and thus contained a sequence very similar to the Nterminal portion.
Finally it should be stressed that the only valid way of proving a diagnosis of the 'ectopic ACTH-MSH' syndrome was the demonstration that extracts of the tumour contained more ACTH-like or MSH-like activity than an equivalent weight of the patient's nontumorous tissue or blood obtained at the same time as the tumour. The mere demonstration of high corticosteroid levels in blood or urine in a patient with cancer was, of itself, insufficient if suggestive evidence, since it had been known for several years that corticosteroid levels were elevated in most patients with terminal cancer (Werk et al. 1963) and it was doubtful if they all had the ectopic ACTH-MSH syndrome.
